7WVP
Cryo-EM structure of SARS-CoV-2 Omicron Spike protein with human ACE2 receptor, C2 state
7WVP の概要
| エントリーDOI | 10.2210/pdb7wvp/pdb |
| EMDBエントリー | 32856 |
| 分子名称 | Angiotensin-converting enzyme 2, Spike glycoprotein (2 entities in total) |
| 機能のキーワード | sars-cov-2, omicron, spike protein, ace2, viral protein, hydrolase-viral protein complex |
| 由来する生物種 | Homo sapiens (human) 詳細 |
| タンパク質・核酸の鎖数 | 4 |
| 化学式量合計 | 493040.37 |
| 構造登録者 | |
| 主引用文献 | Hong, Q.,Han, W.,Li, J.,Xu, S.,Wang, Y.,Xu, C.,Li, Z.,Wang, Y.,Zhang, C.,Huang, Z.,Cong, Y. Molecular basis of receptor binding and antibody neutralization of Omicron. Nature, 604:546-552, 2022 Cited by PubMed Abstract: The SARS-CoV-2 Omicron variant exhibits striking immune evasion and is spreading rapidly worldwide. Understanding the structural basis of the high transmissibility and enhanced immune evasion of Omicron is of high importance. Here, using cryo-electron microscopy, we present both the closed and the open states of the Omicron spike (S) protein, which appear more compact than the counterparts of the G614 strain, potentially related to enhanced inter-protomer and S1-S2 interactions induced by Omicron residue substitution. The closed state showing dominant population may indicate a conformational masking mechanism for the immune evasion of Omicron. Moreover, we captured three states for the Omicron S-ACE2 complex, revealing that the substitutions on the Omicron RBM result in new salt bridges and hydrogen bonds, more favourable electrostatic surface properties, and an overall strengthened S-ACE2 interaction, in line with the observed higher ACE2 affinity of Omicron S than of G614. Furthermore, we determined the structures of Omicron S in complex with the Fab of S3H3, an antibody that is able to cross-neutralize major variants of concern including Omicron, elucidating the structural basis for S3H3-mediated broad-spectrum neutralization. Our findings shed light on the receptor engagement and antibody neutralization or evasion of Omicron and may also inform the design of broadly effective vaccines against SARS-CoV-2. PubMed: 35228716DOI: 10.1038/s41586-022-04581-9 主引用文献が同じPDBエントリー |
| 実験手法 | ELECTRON MICROSCOPY (3.7 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






